FibroBiologics, Inc. Common StockFBLGNASDAQ
Loading
Net Income Growth AcceleratingAccelerating
Percentile Rank93
3Y CAGR+162.2%
Year-over-Year Change
Year-over-year net income growth rate
3Y CAGR
+162.2%/yr
Quarterly compound
Percentile
P93
Near historical high
vs 3Y Ago
18x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 43.86% |
| Q3 2025 | -24.04% |
| Q2 2025 | 6.20% |
| Q1 2025 | -60.25% |
| Q4 2024 | -519.80% |
| Q3 2024 | -155.68% |
| Q2 2024 | 110.61% |
| Q1 2024 | 12.94% |
| Q4 2023 | -343.09% |
| Q3 2023 | -1.53% |
| Q2 2023 | 10.56% |
| Q1 2023 | -58.46% |
| Q4 2022 | 2.43% |
| Q3 2022 | -53.51% |
| Q2 2022 | 0.00% |
| Q1 2022 | 0.00% |